The efficacy and safety of suvemcitug, envafolimab, and FOLFIRI in microsatellite-stable or mismatch repair-proficient colorectal cancer: preliminary results of a phase 2 study
苏维西妥、恩伐利单抗和FOLFIRI方案治疗微卫星稳定型或错配修复功能正常的结直肠癌的疗效和安全性:一项II期研究的初步结果
期刊:International Journal of Colorectal Disease
影响因子:2.3
doi:10.1007/s00384-025-04806-z
Liu, Ying; Wang, Jufeng; Fang, Yong; Deng, Yanhong; Hu, Changlu; Fan, Qingxia; Gu, Kangsheng; Zhang, Yu; Yang, Chen; Liu, Zhenru; Tian, Ji; Sun, Xiyang; Sun, Shuguang; Cheng, Ying